KYMR PEER ANALYSIS

Kymera Therapeutics Inc — metric-by-metric comparison with peers and the industry median

KYMRKymera Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

KYMRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	KYMR	CSL	TLX	MSB	Ind. Median
P/E	—	29.96	—	—	18.06
P/B	7.55	2.24●	6.38	—	3.62
EV/EBITDA	—	10.35●	120.20	—	15.13
P/S	225.98	2.66●	3.24	31.30	10.65

Financial Health
Metric	KYMR	CSL	TLX	MSB	Ind. Median
Current Ratio	10.81●	2.57	1.43	—	5.90
Debt/Equity	5.2%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	1.86●	2.22	13.13	—	1.15

Profitability
Metric	KYMR	CSL	TLX	MSB	Ind. Median
Net Margin	-612.2%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	-27.1%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-24.4%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	-594.7%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	KYMR	CSL	TLX	MSB	Ind. Median
Rev. Growth	-12.6%	4.8%	56.3%	410.4%●	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	KYMR	TECH	KRYS	CYTK	BMRN	ARWR	Ind. Median
P/E	—	101.14	49.97	—	44.39●	—	18.06
P/B	7.55	5.31	8.81	-12.76●	1.92	20.17	3.62
EV/EBITDA	—	43.27	51.98	—	23.10●	—	15.13
P/S	225.98	9.15	26.95	99.68	3.68●	19.91	10.65

Financial Health
Metric	KYMR	TECH	KRYS	CYTK	BMRN	ARWR	Ind. Median
Current Ratio	10.81●	4.49	9.46	4.21	5.81	6.23	5.90
Debt/Equity	5.2%	13.9%	0.7%	-155.9%●	23.2%	223.7%	10.9%
NetDebt/EBITDA	1.86	0.31	-4.06●	-0.64	-1.62	3.06	1.15

Profitability
Metric	KYMR	TECH	KRYS	CYTK	BMRN	ARWR	Ind. Median
Net Margin	-612.2%	9.0%	53.9%●	-784.0%	8.3%	-48.4%	-125.7%
ROE	-27.1%	5.3%	19.9%●	—	4.5%	-46.4%	-47.5%
ROA	-24.4%	4.2%	18.2%●	-65.4%	3.4%	-15.7%	-35.8%
EBITDA Margin	-594.7%	21.3%	48.1%●	-694.3%	14.9%	-21.6%	-105.8%

Growth + Dividend
Metric	KYMR	TECH	KRYS	CYTK	BMRN	ARWR	Ind. Median
Rev. Growth	-12.6%	0.2%	25.1%	450.6%●	9.9%	9.4%	5.1%
NI Growth	—	-16.8%	81.5%●	—	-48.7%	—	12.1%
Div. Yield	—	0.5%●	—	—	—	0.3%	0.2%
Payout	—	45.5%	—	—	—	-13.8%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on KYMR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.